Radiotherapy for Elderly Bladder Cancer Patients
Author Information
Author(s): Hsieh Chen-Hsi, Chung Shiu-Dong, Chan Pei-Hui, Lai Siu-Kai, Chang Hsiao-Chun, Hsiao Chi-Huang, Wu Le-Jung, Chong Ngot-Swan, Chen Yu-Jen, Wang Li-Ying, Hsieh Yen-Ping, Shueng Pei-Wei
Primary Institution: Far Eastern Memorial Hospital, Taipei, Taiwan
Hypothesis
To evaluate treatment planning using intensity-modulated radiotherapy (IMRT) and helical tomotherapy (HT) for elderly patients with bladder cancer.
Conclusion
IMRT and HT provide good locoregional progression-free survival with tolerable toxicity for elderly patients with invasive bladder cancer.
Supporting Evidence
- Median survival was 21 months for the patients.
- 89.5% of patients had no local recurrence.
- 2-year overall survival rates were 26.3% for IMRT and 37.5% for HT.
Takeaway
Doctors used special radiation techniques to treat older people with bladder cancer, and they found that these methods worked well without causing too much harm.
Methodology
The study involved 19 elderly patients treated with either IMRT or HT, comparing their outcomes to conventional radiation therapy.
Limitations
The study had a small sample size and was retrospective in nature.
Participant Demographics
Median age was 80 years, with 14 men and 5 women.
Statistical Information
P-Value
0.004
Statistical Significance
p = 0.004
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website